SCHEMBL8097387

SCHEMBL8097387

O=C(Cl)C1(c2cccc([N+](=O)[O-])c2)CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
TSHR P16473 4/20 0.50
KDM1A O60341 1/20 0.48
LMNA P02545 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CES2 O00748 1/20 0.45
CES1 P23141 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MAPT P10636 2/20 0.45
PTBP1 P26599 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALOX15 P16050 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CHRNA1 P02708 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676255 0.87 AKR1C1 (0.53) ALDH1A1TSHRKDM1ALMNACES2
SCHEMBL6676866 0.84 AKR1C1 (0.57) ALDH1A1TSHRKDM1ALMNACES2
SCHEMBL6674979 0.82 AKR1C1 (0.56) ALDH1A1TSHRKDM1ALMNACES2
SCHEMBL15054545 0.82 SLC6A4 (0.46) ALDH1A1TSHRKDM1ALMNANPSR1
SCHEMBL5369238 0.81 NPSR1 (0.53) ALDH1A1TSHRLMNACES1NPSR1
SCHEMBL30492221 0.81 KDM1A (0.50) ALDH1A1TSHRKDM1ALMNARXFP1
SCHEMBL6679093 0.80 TP53 (0.51) ALDH1A1TSHRKDM1ALMNACES2
SCHEMBL27256555 0.80 NPSR1 (0.46) ALDH1A1TSHRKDM1ALMNACES2
SCHEMBL15054977 0.79 MEN1 (0.48) ALDH1A1TSHRKDM1ALMNANPSR1
SCHEMBL15271889 0.79 KDM1A (0.54) ALDH1A1TSHRKDM1ALMNACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124354-A TREATMENT OF URINARY INCONTINENCE OR IRRITABLE BOWEL SYNDROME PHARMACIA & UPJOHN AB (SE) 2000-09-26 US disclosed
EP-0923536-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1999-06-23 EP disclosed
WO-1998004517-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-02-05 WO disclosed